Why Firms Are Engaging CEOs Earlier—Long Before a Sale Is Planned
Why Firms Are Engaging CEOs Earlier—Long Before a Sale Is Planned Key Takeaways The M&A Shift CEOs Can’t Ignore In healthcare M&A, the biggest change over the last few years hasn’t been deal volume or valuation multiples—it’s when CEOs start preparing. Traditionally, CEOs engaged advisors only after deciding to sell. Today, that approach is increasingly […]
Read More
Treatment Bundling as a Strategic Lever, Not a Marketing Tactic
Treatment Bundling as a Strategic Lever, Not a Marketing Tactic Key Takeaways Why Treatment Bundling Is No Longer Optional in Modern Healthcare Healthcare organizations are operating in an environment where cost pressure, payer scrutiny, and outcome accountability are intensifying simultaneously. Traditional fee-for-service models—once the backbone of healthcare revenue—are increasingly misaligned with how care is evaluated, […]
Read More